Compare Humana Inc (HUM) vs Innovative Industrial Properties Inc (IIPR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Innovative Industrial Properties Inc — how do they compare? Humana Inc trades at $374.25 (market cap $46.31B), while Innovative Industrial Properties Inc trades at $58.5 (market cap $1.66B). The key difference: Humana Inc is far larger — about 27.9× Innovative Industrial Properties Inc's market cap, and Innovative Industrial Properties Inc pays the higher dividend (13.24%). Which is the better fit depends on your goals.
| HUM | IIPR | |
|---|---|---|
Market Cap | $46.31B | $1.66B |
Sector | Health | Real Estate |
52-Week High | $409.42 | $64.67 |
52-Week Low | $163.67 | $44.58 |
Enterprise Value | $53.67B | $2.20B |
Dividend Yield | 0.92% | 13.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
IIPR trades at $59.16, up 1.46% on the day, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 revenue of $63.3M and FFO of $1.83 per share, beating estimates (Zacks, August 3, 2026). Financials show a net income margin of 52.27% for 2025, though revenue declined to $266M from $309M in 2024. The balance sheet remains solid with total assets of $2.38B and a low debt-to-asset ratio of 16.58% as of 2025.
Outlook is cautious; analyst consensus is mixed with 36% buy ratings. Key risks include tenant distress impacting cash flow and regulatory uncertainty in the cannabis sector. The stock offers a dividend yield but faces headwinds from declining revenue and high payout ratios. Investment appeal hinges on execution in life sciences and cannabis leasing growth amid competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Innovative Industrial Properties Inc
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.
Read more on IIPR →
